Appropriate pharmacology should be initiated before, during and following percutaneous coronary intervention in patients with left ventricular dysfunction or heart failure

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.6, 2007-06, pp. : 16-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention

By Lipinski Michael J.   Vetrovec George W.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 313-325

Adis International

Access to resources Recommend Favorite

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart Failure

By Levine T.   Giles Thomas   Radzik David   Ghali Jalal  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 449-458

Springer Publishing Company

Access to resources Recommend Favorite

Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction

By van Kraaij D.J.W.  

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 289-300

Adis International

Access to resources Recommend Favorite

Valsartan: A Review of its Use in Patients with Heart Failure and/or Left Ventricular Systolic Dysfunction After Myocardial Infarction

By Katherine F. Croom   Gillian M. Keating  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 395-404

Adis International

Access to resources Recommend Favorite

The treatment of chronic heart failure due to left ventricular systolic dysfunction

By Gardner R S   McDonagh T A  

Clinical Medicine, Vol. 4, Iss. 1, 2004-01 ,pp. : 18-22

Royal College Of Physicians

Access to resources Recommend Favorite